In the presence of hepatic steatosis, various intermediate lipid moieties generated during triglyceride synthesis (e.g., diacylglycerols and ceramide) have been shown to promote lipotoxicity and enhance hepatic insulin resistance (46, 47), likely by inhibiting insulin signaling pathways (48, 49). This evidence concerns the gene INS and fatty liver disease.